National Amphetamine-Type Stimulant Strategy 2008-2011
1.4 What is the National Amphetamine-Type Stimulant Strategy?
- Abbreviations
- Executive summary
1. Introduction- 1.1 What are amphetamine-type stimulants?
- 1.2 Who uses ATS, what influences use and how are ATS used?
- 1.3 Why does Australia need a National Amphetamine-Type Stimulant Strategy?
- 1.4 What is the National Amphetamine-Type Stimulant Strategy?
- 1.5 What is already being done?
- 1.6 How has the Strategy been developed?
- 1.7 What issues were identified?
- 2. Strategic Framework
3. Priority Areas- 4. Where next?
- Appendix 1
- Appendix 2
- References
On 15 May 2006, the Ministerial Council on Drug Strategy (MCDS) supported a resolution to develop a National Amphetamine-Type Stimulant (ATS) Strategy. The MCDS is the peak policy and decision making body on licit and illicit drugs in Australia, and is responsible for developing policies and programs to reduce the demand, supply and harm associated with drugs and their impact on individuals, families and communities in Australia. It brings together Australian government, state and territory ministers responsible for health and law enforcement, and the Australian government minister responsible for education.
The National ATS Strategy was developed in the context of the National Drug Strategy 2005-2009 that encompasses:
- Supply reduction strategies to disrupt the production and supply of illicit drugs and to control and regulate licit substances;
- Demand reduction strategies to prevent the uptake of harmful drug use, including abstinence-oriented strategies and treatment to reduce drug use; and
- Harm reduction strategies to reduce drug-related harm to individuals and communities.
- National Drug Strategy Aboriginal and Torres Strait Islander Peoples Complementary
- National Strategic Framework for Aboriginal and Torres Strait Islander Peoples Mental Action Plan 2003-2009; Health and Social and Emotional Wellbeing 2004-2009;
- National Strategic Framework for Aboriginal and Torres Strait Islander Health 2003-2013;
- National Aboriginal and Torres Strait Islander Sexual Health and Blood Borne Virus Strategy 2005-08;
- National Tobacco Strategy 2004-2009;
- National Alcohol Strategy 2006-2009;
- National Cannabis Strategy 2006-2009;
- National School Drug Education Strategy 1999 and Department of Education, Science and Training Principles for School Drug Education 2004;
- National Mental Health Plan 2003-2008;
- National Action Plan for Promotion, Prevention and Early Intervention in Mental Health 2000;
- National Suicide Prevention Strategy 1999;
- National Hepatitis C Strategy 2005-2008;
- National HIV/AIDS Strategy 2005-2008;
- National Strategy to Prevent the Diversion of Precursor Chemicals into Illicit Drug Manufacture (National Precursor Strategy) 2003/04; and
- National Comorbidity Initiative 2003/04 – 2007/08.
